Neurologic Phenotypes Associated With Mutations in RTN4IP1 (OPA10) in Children and Young Adults by M. Charif et al.
Neurologic Phenotypes Associated With Mutations in
RTN4IP1 (OPA10) in Children and Young Adults
Submitted by Beatrice Guillaumat on Wed, 08/28/2019 - 12:37
Titre Neurologic Phenotypes Associated With Mutations in RTN4IP1 (OPA10) in Childrenand Young Adults
Type de
publication Article de revue
Auteur
Charif, Majida [1], Nasca, Alessia [2], Thompson, Kyle [3], Gerber, Sylvie [4],
Makowski, Christine [5], Mazaheri, Neda [6], Bris, Céline [7], Goudenège, David [8],
Legati, Andrea [9], Maroofian, Reza [10], Shariati, Gholamreza [11], Lamantea,
Eleonora [12], Hopton, Sila [13], Ardissone, Anna [14], Moroni, Isabella [15],
Giannotta, Melania [16], Siegel, Corinna [17], Strom, Tim M [18], Prokisch, Holger
[19], Vignal-Clermont, Catherine [20], Derrien, Sabine [21], Zanlonghi, Xavier [22],
Kaplan, Josseline [23], Hamel, Christian [24], Leruez, Stéphanie [25], Procaccio,
Vincent [26], Bonneau, Dominique [27], Reynier, Pascal [28], White, Frances E [29],
Hardy, Steven A [30], Barbosa, Inês A [31], Simpson, Michael A [32], Vara, Roshni
[33], Perdomo-Trujillo, Yaumara [34], Galehdari, Hamind [35], Deshpande, Charu [36],
Haack, Tobias B [37], Rozet, Jean-Michel [38], Taylor, Robert W. [39], Ghezzi, Daniele
[40], Amati-Bonneau, Patrizia [41], Lenaers, Guy [42]
Editeur American Medical Association










Importance: Neurologic disorders with isolated symptoms or complex syndromes are
relatively frequent among mitochondrial inherited diseases. Recessive RTN4IP1 gene
mutations have been shown to cause isolated and syndromic optic neuropathies.
Objective: To define the spectrum of clinical phenotypes associated with mutations in
RTN4IP1 encoding a mitochondrial quinone oxidoreductase.
Design, Setting, and Participants: This study involved 12 individuals from 11 families
with severe central nervous system diseases and optic atrophy. Targeted and whole-
exome sequencing were performed-at Hospital Angers (France), Institute of
Neurology Milan (Italy), Imagine Institute Paris (France), Helmoltz Zentrum of
Munich (Germany), and Beijing Genomics Institute (China)-to clarify the molecular
diagnosis of patients. Each patient's neurologic, ophthalmologic, magnetic resonance
imaging, and biochemical features were investigated. This study was conducted from
May 1, 2014, to June 30, 2016.
Main Outcomes and Measures: Recessive mutations in RTN4IP1 were identified.
Clinical presentations ranged from isolated optic atrophy to severe encephalopathies.
Results: Of the 12 individuals in the study, 6 (50%) were male and 6 (50%) were
female. They ranged in age from 5 months to 32 years. Of the 11 families, 6 (5 of
whom were consanguineous) had a member or members who presented isolated optic
atrophy with the already reported p.Arg103His or the novel p.Ile362Phe, p.Met43Ile,
and p.Tyr51Cys amino acid changes. The 5 other families had a member or members
who presented severe neurologic syndromes with a common core of symptoms,
including optic atrophy, seizure, intellectual disability, growth retardation, and
elevated lactate levels. Additional clinical features of those affected were deafness,
abnormalities on magnetic resonance images of the brain, stridor, and abnormal
electroencephalographic patterns, all of which eventually led to death before age 3
years. In these patients, novel and very rare homozygous and compound heterozygous
mutations were identified that led to the absence of the protein and complex I
disassembly as well as mild mitochondrial network fragmentation.
Conclusions and Relevance: A broad clinical spectrum of neurologic features, ranging
from isolated optic atrophy to severe early-onset encephalopathies, is associated with
RTN4IP1 biallelic mutations and should prompt RTN4IP1 screening in both syndromic
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